Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine

"Identification and validation of mutations in individual breast cancers provides an unprecedented opportunity to target unique tumor antigens with personalized breast cancer vaccines," the researchers wrote in their project abstract.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.